Concord Drugs Share Price

ABOUT Concord Drugs

• Industry Biotechnology & Drugs
• ISIN INE858L01010
• BSE Code 538965

Concord Drugs Limited is an India-based pharmaceutical company. The Company's principal activity is to manufacture licensed drugs based on the formulations approved. The Company is focused on developing drug delivery systems, including multiple unit pellet system (MUPS), sustained release, and modified release pellets. It operates a Current Good Manufacturing Practice (cGMP) contract manufacturing formulation-fill-finish facility, offering a full spectrum of pharmaceutical development and manufacturing services for drug products. The Company's products include pharmaceutical ready to fill pellets, MUPS; tissue bio adhesive; injectables (small volume parenterals); oral solid dosages (tablets); oral solid dosages (capsules); liquid orals, and dry syrup (powder). It also offers hand sanitizers under the brand name, PROTON SAFE. It manufactures hand sanitizers on third party basis also. The Company's oral liquid dosage forms include solutions, syrups, and suspensions.

MANAGEMENT

• Seelam Reddy Executive Chairman of the Board, Managing Director
• Seelam Reddy Chief Financial Officer, Whole time Director
• Namratha Nagla Compliance Officer, Company Secretary
• S. Manoj Reddy Additional Whole-Time Director